慢性疼痛管理市場向け多血小板血漿 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00017231
  • Category : Healthcare IT
  • No. of Pages : 150
Buy Now

Platelet Rich Plasma for Chronic Pain Management Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

市場概要 多血小板血漿 (PRP) は、アルファ顆粒内の生理活性分子と成長因子の作用により組織を再構築し、痛みを軽減します。利用可能な PRP 調製システムはいくつかあり、それぞれ最終製品、成長因子の投与量、生理活性化合物が異なります。新しい治療法を開発するための広範な研究開発活動と慢性疼痛の有病率の増加が市場成長の原動力となっています。 市場範囲 「2031 年までの慢性疼痛治療のための多血小板血漿の世界市場分析」は、世界市場の傾向分析に特に焦点を当てたヘルスケア業界の専門的で詳細な調査です。レポートの目的は、適応症ごとの詳細な市場分割とともに、慢性疼痛治療のための多血小板血漿市場の概要を提供することです。このレポートは、慢性疼痛治療市場プレーヤー向けの主要な多血小板血漿の市場状況に関する重要な統計を提供し、市場の主要な傾向と機会を提供します。 市場セグメンテーション
    • 適応症に基づいて、市場は腱炎、関節炎、テニス肘、膝の怪我、靱帯断裂、肩の怪我、片頭痛、慢性頭痛、首と背中の怪我に分類されます。
MARKD TYNAMICS ドライバー:
    • 慢性的な痛み、整形外科疾患、スポーツ傷害の有病率が増加しています。 • 新しい治療法を開発して市場に投入するための、バイオ医薬品および製薬会社による強力な研究開発努力。 • 製薬会社による血液および血液療法への重点の増加が市場の成長を支援すると予想されます。
制限事項:
    • 多血小板血漿の高コストと厳格な規制枠組みにより、予測期間中の市場の成長が抑制されると予想されます。
このレポートは、定性的および定量的な情報を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいた世界市場の概要と予測を提供します。また、北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、南米の 5 つの主要地域に関して、2021 年から 2031 年の市場規模と予測推定値も提供します。地域別の慢性疼痛治療市場における多血小板血漿は、後に国とセグメントに分割されます。このレポートは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会をカバーしています。レポートは、需要側と供給側の両方で市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場のダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートはまた、北米、ヨーロッパ、APAC、MEA、南米の5つの地域すべての包括的な害虫分析も提供しています。これらの地域の慢性疼痛治療用多血小板血漿市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後です。 慢性疼痛治療用多血小板血漿市場に対する新型コロナウイルス感染症(COVID-19) の影響 新型コロナウイルス感染症(COVID-19)は、2021年12月に中国の武漢で初めて発生し、その後急速に世界中に広がりました。米国、インド、ブラジル、ロシア、フランス、英国、トルコ、イタリア、スペインは、感染者数と死亡報告数の点で最も大きな打撃を受けている国の一つである。新型コロナウイルス感染症危機は、ロックダウン、渡航禁止、事業閉鎖により、さまざまな国の経済や産業に影響を与えています。さまざまな工場や工場の閉鎖は世界のサプライチェーンに影響を及ぼし、世界市場での製品の製造、配送スケジュール、販売に悪影響を及ぼしています。製品納期の遅延や将来の製品売上減少の可能性をすでに発表している企業はほとんどありません。現在の市場状況に従って、レポートは新型コロナウイルス感染症パンデミックが市場全体に及ぼす現在および将来の影響をさらに評価し、より信頼性が高く信頼性の高い予測を提供します。さらに、ヨーロッパ、アジア太平洋、北米の国々からの世界的な渡航禁止は、ビジネスコラボレーションやパートナーシップの機会に影響を与えています。 市場関係者 このレポートでは、有機的および無機的な成長戦略だけでなく、慢性疼痛治療のための多血小板血漿市場の主要な動向について取り上げています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で観察された無機的な成長戦略は、買収、パートナーシップ、コラボレーションでした。これらの活動により、市場参加者のビジネスと顧客ベースの拡大への道が開かれました。世界市場で慢性疼痛治療用の多血小板血漿の需要が高まっているため、慢性疼痛治療用の多血小板血漿市場のプレーヤーは将来的に有利な成長機会を得ることが期待されています。レポートには、慢性疼痛治療用多血小板血漿市場におけるSWOT分析および市場戦略とともに主要企業のプロフィールも含まれています。さらに、このレポートは、企業概要、提供されるコンポーネントとサービス、過去 3 年間の財務情報、過去 5 年間の主要な開発などの情報を提供する業界の主要企業に焦点を当てています。
    • トライセルバイオ • 株式会社アースレクス •  Isto Biologics • リジェンケア • 医療機器ビジネスサービス株式会社 • 博士。 PRP USA LLC • エムサイト株式会社 • グロフィン・オイ • テルモBCT株式会社 •  Zimmer Biomet
Insight パートナーの専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の調査に対してさまざまなカスタマイズ オプションを提供しています。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. Tricell Bio
2. Arthrex Inc.
3. Isto Biologics
4. Regencare
5. Medical Devices Business Services, Inc.
6. Dr. PRP USA LLC
7. EmCyte Corporation
8. Glofinn Oy
9. TERUMO BCT, INC
10. Zimmer Biomet

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Healthcare IT : READ MORE..